Table 1 Means (SD) of MRS scores at baseline (before therapy) and at end of observation (after therapy. Improvement of scores after therapy by absolute difference in scoring points. §Total scale and for each subscale.
From: The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study
n | Scores before | Scores after | Absolute change | Percent (%) change | P** | |
|---|---|---|---|---|---|---|
Total scale | 9311 | 11.0 (8.2) | 1.7 (3.2) | 9.3 (7.4) | 36.1 (20.6) | <0.0001 |
Psychological subscale | 9311 | 4.5 (4.1) | 0.7 (1.7) | 3.8 (3.7) | 34.5 (27.1) | <0.0001 |
Somatic subscale | 9311 | 4.2 (3.2) | 0.5 (1.2) | 3.6 (3.0) | 37.3 (23.1) | <0.0001 |
Urogenital subscale | 9311 | 2.3 (2.6) | 0.5 (1.1) | 1.8 (2.3) | 24.5 (25.3) | <0.0001 |